Cellular
senescence
is
a
cell
fate
that
occurs
in
response
to
numerous
types
of
stress
and
can
promote
tissue
repair
or
drive
inflammation
disruption
homeostasis
depending
on
the
context.
Aging
obesity
lead
an
increase
senescent
burden
multiple
organs.
Senescent
cells
release
myriad
senescence-associated
secretory
phenotype
factors
directly
mediate
pancreatic
β-cell
dysfunction,
adipose
insulin
resistance
peripheral
tissues,
which
onset
type
II
diabetes
mellitus.
In
addition,
hyperglycemia
metabolic
changes
seen
cellular
senescence.
Diabetes-induced
contributes
various
diabetic
complications.
Thus,
both
cause
consequence
This
review
summarizes
recent
studies
link
between
aging,
obesity,
diabetes,
focusing
role
disease
processes.
FEBS Journal,
Год журнала:
2022,
Номер
290(5), С. 1362 - 1383
Опубликована: Янв. 11, 2022
The
concept
of
geroscience
is
that
since
ageing
the
greatest
risk
factor
for
many
diseases
and
conditions,
targeting
process
itself
will
have
impact
on
human
health.
Of
hallmarks
ageing,
cellular
senescence
has
emerged
as
a
druggable
therapeutic
target
extending
healthspan
in
model
organisms.
Cellular
cell
state
irreversible
proliferative
arrest
driven
by
different
types
stress,
including
oncogene‐induced
stress.
Many
senescent
cells
(SnCs)
develop
senescent‐associated
secretory
phenotype
(SASP)
comprising
pro‐inflammatory
cytokines,
chemokines,
proteases,
bioactive
lipids,
inhibitory
molecules,
extracellular
vesicles,
metabolites,
lipids
other
factors,
able
to
promote
chronic
inflammation
tissue
dysfunction.
SnCs
up‐regulate
anti‐apoptotic
pathways
(SCAPs)
prevent
them
from
dying
despite
accumulation
damage
DNA
organelles.
These
SCAPs
altered
represent
targets
development
senotherapeutic
drugs
induce
selective
death
SnCs,
specifically
termed
senolytics
or
suppress
markers
senescence,
particular
SASP,
senomorphics.
Here,
we
review
current
senomorphics
treatment
age‐related
disorders
extension
healthy
longevity.
In
addition,
challenges
documenting
senolytic
senomorphic
activity
pre‐clinical
models
clinical
application
senotherapeutics
be
discussed.
The
COVID-19
pandemic
has
revealed
the
pronounced
vulnerability
of
elderly
and
chronically
ill
to
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)-induced
morbidity
mortality.
Cellular
senescence
contributes
inflammation,
multiple
chronic
diseases,
age-related
dysfunction,
but
effects
on
responses
viral
infection
are
unclear.
Here,
we
demonstrate
that
senescent
cells
(SnCs)
become
hyper-inflammatory
in
response
pathogen-associated
molecular
patterns
(PAMPs),
including
SARS-CoV-2
spike
protein-1,
increasing
expression
entry
proteins
reducing
antiviral
gene
non-SnCs
through
a
paracrine
mechanism.
Old
mice
acutely
infected
with
pathogens
included
SARS-CoV-2-related
mouse
β-coronavirus
experienced
increased
nearly
100%
Targeting
SnCs
by
using
senolytic
drugs
before
or
after
pathogen
exposure
significantly
reduced
mortality,
cellular
senescence,
inflammatory
markers
antibodies.
Thus,
SnC
burden
diseased
aged
individuals
should
enhance
resilience
reduce
mortality
infection,
SARS-CoV-2.
JNCI Journal of the National Cancer Institute,
Год журнала:
2021,
Номер
113(10), С. 1285 - 1298
Опубликована: Март 31, 2021
Cellular
senescence
is
an
essential
tumor
suppressive
mechanism
that
prevents
the
propagation
of
oncogenically
activated,
genetically
unstable,
and/or
damaged
cells.
Induction
cell
also
one
underlying
mechanisms
by
which
cancer
therapies
exert
antitumor
activity.
However,
increasing
body
evidence
from
preclinical
studies
demonstrates
radiation
and
chemotherapy
cause
accumulation
senescent
cells
(SnCs)
both
in
normal
tissue.
SnCs
tumors
can,
paradoxically,
promote
relapse,
metastasis,
resistance
to
therapy,
part,
through
expression
senescence-associated
secretory
phenotype.
In
addition,
tissue
can
contribute
certain
radiation-
chemotherapy-induced
side
effects.
Because
its
multiple
roles,
cellular
could
serve
as
important
target
fight
against
cancer.
This
commentary
provides
a
summary
discussion
at
National
Cancer
Institute
Workshop
on
Radiation,
Senescence,
(August
10-11,
2020,
Institute,
Bethesda,
MD)
regarding
current
status
research,
heterogeneity
therapy-induced
senescence,
senotherapeutics
molecular
biomarkers,
concept
"one-two
punch"
therapy
(consisting
therapeutics
induce
followed
selective
clearance
SnCs),
integration
with
personalized
adaptive
therapy.
It
identifies
key
knowledge
gaps
outlines
future
directions
this
emerging
field
improve
treatment
outcomes
for
patients.
FEBS Journal,
Год журнала:
2022,
Номер
290(5), С. 1186 - 1202
Опубликована: Янв. 20, 2022
Senescence
is
a
multi-functional
cell
fate,
characterized
by
an
irreversible
cell-cycle
arrest
and
pro-inflammatory
phenotype,
commonly
known
as
the
senescence-associated
secretory
phenotype
(SASP).
Emerging
evidence
indicates
that
accumulation
of
senescent
cells
in
multiple
tissues
drives
tissue
dysfunction
several
age-related
conditions.
This
has
spurred
academic
community
industry
to
identify
new
therapeutic
interventions
targeting
this
process.
Mitochondrial
often-unappreciated
hallmark
cellular
senescence
which
plays
important
roles
not
only
growth
but
also
development
SASP
resistance
cell-death.
Here,
we
review
supports
role
for
mitochondria
describe
underlying
mechanisms.
Finally,
propose
detailed
road
map
mitochondrial
biology
will
be
crucial
guide
future
senotherapies.
International Journal of Molecular Sciences,
Год журнала:
2021,
Номер
22(7), С. 3553 - 3553
Опубликована: Март 29, 2021
Bone
is
a
dynamic
organ
maintained
by
tightly
regulated
mechanisms.
With
old
age,
bone
homeostasis,
which
an
intricate
balance
between
formation
and
resorption,
undergoes
deregulation.
Oxidative
stress-induced
DNA
damage,
cellular
apoptosis,
senescence
are
all
responsible
for
this
tissue
dysfunction
the
imbalance
in
homeostasis.
These
mechanisms
have
become
target
therapeutics
to
treat
age-related
osteoporosis.
Genetic
mouse
models
shown
importance
of
senescent
cell
clearance
alleviating
Furthermore,
we
others
that
targeting
pharmacologically
was
effective
tool
alleviate
age-
radiation-induced
Senescent
cells
also
altered
secretome
known
as
associated
secretory
phenotype
(SASP),
may
autocrine,
paracrine,
or
endocrine
function.
The
current
review
discusses
potential
pathways
lead
profile
aged
skeleton
how
homeostasis
affected
during
has
discussed
existing
treatment
osteoporosis
rationalizes
novel
therapeutic
options
based
on
SASP
underlying
pathogenesis
aging
bone.
Oxidative Medicine and Cellular Longevity,
Год журнала:
2022,
Номер
2022, С. 1 - 23
Опубликована: Окт. 19, 2022
Reactive
oxygen
species
(ROS)
are
bioproducts
of
cellular
metabolism.
There
is
a
range
molecules
with
oxidizing
properties
known
as
ROS.
Despite
those
being
implied
negatively
in
aging
and
numerous
diseases,
their
key
role
signaling
evident.
ROS
control
several
biological
processes
such
inflammation,
proliferation,
cell
death.
The
redox
underlying
these
events
one
characteristic
the
new
generation
scientists
aimed
at
defining
environment.
potential,
which
includes
balance
sources
antioxidant
system,
implies
an
important
target
for
understanding
cells’
fate
derived
from
signaling.
In
this
review,
we
summarized
chemical,
balance,
signaling,
implications
aging.